Diabetes Flashcards
Diagnosis of DMII made on…?
HbA1c > 48mmol/mol
Random plasma Glucose > 11.1mmol/mol
Fasting plasma glucose > 7mmol/mol
Factors affecting HbA1c?
Haemolysis (low) Iron deficiency anaemia Renal impairment Pregnancy Blood transfusion
Pre-diabetes HbA1c?
43-48mmol/mol
HbA1c treatment target for patients taking hypoglycaemic-associated drugs?
53mmol/mol
Hypo-associated drugs eg sulfonylureas
Initial diabetic drug treatment?
Metformin, titrated up to reduce risk of adverse GI effects
MONITOR RENAL FUNCTION BEFORE AND AFTER STARTING
Drug treatment after metformin or if contraindicated?
1 - gliptin (DPP-4)
2 - pioglitazone
3 - sulfonylurea
When to add insulin?
Consider when ineffective double/triple therapy (metformin + other x2),
(Or if other drugs are contraindicated/not tolerated)
Metformin MOA
Metformin is a biguanide (Acts on AMPK) Decrease hepatic gluconeogenesis Increase insulin sensitivity Increase peripheral glucose uptake Decrease gut absorption of glucose
Sulfonylureas MOA
Bind to pancreatic receptors
Increase insulin production (hence hypo risk)
Pioglitazone MOA
Pioglitazone is a thiazolidinedione
(Acts on PPAR alpha and gamma)
Increase insulin sensitivity in lots of tissues
Decrease visceral fat
GLP-1 (Incretin) MOA
Glucagon-like-peptide mimetic
Causes insulin secretion
(minor hypo risk)
Gliptin MOA
DPP-4 inhibitor
Prevents inactivation of endogenous GLP-1
Sulfonylurea contraindications/cautions
Contra: acute porphyria
Cautions: renal impairment
Metformin contraindications/cautions
Contra: ketoacidosis
Cautions: avoid in severe renal impairment
Pioglitazone contraindications/cautions
Contra: Heart failure; bladder cancer
Cautions: monitor liver function, avoid if impairment/disease